Therapeutic efficacy and safety of pathogen-reduced platelet components: Results of a meta-analysis of randomized controlled trials.

Cid, Joan; Charry, Paola; Lozano, Miquel

Cid, Joan; Charry, Paola; Lozano, Miquel.

Afiliação

Cid J; Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Charry P; Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Lozano M; Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.

Vox Sang ; 119(3): 203-211, 2024 Mar.

Article em En | MEDLINE | ID: mdl-38181391

Assuntos

Transfusão de Plaquetas; Trombocitopenia; Adulto; Humanos; Transfusão de Plaquetas/efeitos adversos; Ensaios Clínicos Controlados Aleatórios como Assunto; Plaquetas; Trombocitopenia/complicações; Hemorragia/etiologia

Palavras-chave

amotosalen; meta-analysis; pathogen reduction; platelet transfusion; riboflavin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Transfusão de Plaquetas Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google